Editorial: Accumulating Evidence for the Benefit of Micronutrients for Children With Attention-Deficit/Hyperactivity Disorder

• Published in: Journal of the American Academy of Child and Adolescent Psychiatry Vol. 61; no. 5; pp. 599 - 600
• Main Author: Stevenson, Jim
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.05.2022; Elsevier BV
• Subjects: Adolescent; Adolescents; Amphetamines; Amphetamines - therapeutic use; Atomoxetine; Atomoxetine Hydrochloride - pharmacology; Atomoxetine Hydrochloride - therapeutic use; Attention Deficit Disorder with Hyperactivity - drug therapy; Attention deficit hyperactivity disorder; Behavior modification; Central nervous system; Central Nervous System Stimulants - therapeutic use; Child; Children; Clonidine; Dietary supplements; Drug abuse; Drugs; Efficacy; Emotional regulation; Humans; Hyperactivity; Intervention; Irritability; Methylphenidate; Methylphenidate - pharmacology; Methylphenidate - therapeutic use; Micronutrients; Micronutrients - therapeutic use; Nervous system; Pediatrics; Psychiatric/Mental Health; Stimulants; Substance abuse treatment; Teenagers; Treatment needs; Youth

The first paper indicating that a central nervous system stimulant (amphetamine) could be beneficial for children with attention-deficit/hyperactivity disorder (ADHD)−like behavioral symptoms appeared in 1937.1 Over the subsequent 80 years, a range of additional stimulant (methylphenidate) and nonst...